These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 32723624)

  • 1. Characterization of inflammatory bowel disease in Colombia: Results of a national register.
    Juliao-Baños F; Puentes F; López R; Saffon MA; Reyes G; Parra V; Galiano MT; Barraza M; Molano J; Álvarez E; Corrales R; Vargas LE; Gil F; Álvarez P; Limas L; Prieto R; Yance P; Díaz F; Bareño J; ;
    Rev Gastroenterol Mex (Engl Ed); 2021; 86(2):153-162. PubMed ID: 32723624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia.
    Parra-Izquierdo V; Flórez Sarmiento C; Frías-Ordoñez JS; Vargas M; Kock J; Lozano Escobar N; Márquez JR
    Gastroenterol Hepatol; 2023 Oct; 46(8):585-593. PubMed ID: 36464080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study.
    Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA
    Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
    Guan DX; Yu FH; Wang GL; Zhou J; Wang DY; Nie XL; Xu XW
    Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):493-498. PubMed ID: 28728256
    [No Abstract]   [Full Text] [Related]  

  • 6. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial aggregation of inflammatory bowel disease in India: prevalence, risks and impact on disease behavior.
    Banerjee R; Pal P; Hutfless S; Ganesh BG; Reddy DN
    Intest Res; 2019 Oct; 17(4):486-495. PubMed ID: 31370386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
    Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
    World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
    Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
    Kristensen MS; Kjærulff TM; Ersbøll AK; Green A; Hallas J; Thygesen LC
    Inflamm Bowel Dis; 2019 Apr; 25(5):886-893. PubMed ID: 30551218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
    Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
    Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study.
    Murthy SK; Begum J; Benchimol EI; Bernstein CN; Kaplan GG; McCurdy JD; Singh H; Targownik L; Taljaard M
    Gut; 2020 Feb; 69(2):274-282. PubMed ID: 31196874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.
    Quaresma AB; Coy CSR; Damião AOMC; Kaplan GG; Kotze PG
    Arq Gastroenterol; 2019; 56(3):318-322. PubMed ID: 31633732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of Elderly Onset Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Population-Based Cohort Studies.
    Rozich JJ; Dulai PS; Fumery M; Sandborn WJ; Singh S
    Clin Gastroenterol Hepatol; 2020 Oct; 18(11):2437-2447.e6. PubMed ID: 32142940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Age on the Initiation of Biologic Agent Therapy in Patients With Inflammatory Bowel Disease: Korean Common Data Model Cohort Study.
    Choi YI; Kim YJ; Chung JW; Kim KO; Kim H; Park RW; Park DK
    JMIR Med Inform; 2020 Apr; 8(4):e15124. PubMed ID: 32293578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.
    Niriella MA; Liyanage IK; Kodisinghe SK; De Silva AP; Jayatissa AVGAM; Navarathne NMM; Peiris RK; Kalubovila UP; Kumarasena SR; Jayasekara RW; de Silva HJ
    BMC Gastroenterol; 2021 Feb; 21(1):71. PubMed ID: 33593289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.